Equities

Mahachai Hospital PCL

Mahachai Hospital PCL

Actions
Health CareHealth Care Providers
  • Price (THB)46.50
  • Today's Change-1.75 / -3.63%
  • Shares traded25.90k
  • 1 Year change-32.61%
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mahachai Hospital Public Company Limited is a Thailand-based company engaged in the private hospital business under the name of Mahachai Hospital. The Company’s center and clinics services include Mahachai Heart Center 24 hours, Gastrointestinal and Liver Center, Hematology and Oncology Clinic, Orthopedic Clinic, Eye Clinic, Surgical Clinic, Pulmonary and Respiratory Clinic, Dental and Implant Center, Neurology Clinic, Diabetes Care Center, Internal Medicine Clinic, Sleep Disorders Center, Physical Medicine and Rehabilitation Center, Pediatric Clinic, Ear, Nose and Throat Clinic, Obstetrics and Gynecology Clinic, Urology Clinic, Health Check-up Center, and Kidney and Hemodialysis Center. The Company, through its subsidiaries, operates hospitals under the names, including Mahachai 2 hospital, Mahachai Petcharat hospital, Mahachai 3 hospital, Mahachai Maeklong hospital, Mahachai Prom Pathya hospital, Med park hospital, and others.

  • Revenue in THB (TTM)6.72bn
  • Net income in THB269.55m
  • Incorporated1987
  • Employees422.00
  • Location
    Mahachai Hospital PCL927/43Sethakij 1 Road, Mahachai, Amphoe MuangSAMUT SAKHON 74000ThailandTHA
  • Phone+66 34424990
  • Fax+66 34810782
  • Websitehttps://www.mahachaihospital.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aesthetic Connect PCL645.84m171.07m4.17bn75.0022.422.4122.346.450.53080.53081.974.94------8,611,171.00--------54.01--26.49--13.67348.120.0067---17.08---28.75------
Patrangsit Healthcare Group PCL2.22bn281.47m4.23bn--15.022.0811.481.910.93890.93897.406.761.1030.417.22--13.9114.1416.5518.2026.5325.9712.6811.334.2451.520.0143--4.8110.33-11.4728.30-6.93--
Genesis Fertility Center PCL377.30m87.30m4.36bn97.0024.953.8843.5911.550.39680.39681.722.55------3,889,724.00--------42.96--23.12--4.4917.070.0349--28.51--17.98------
Srivichai Vejvivat PCL2.80bn317.37m4.78bn2.29k14.021.449.661.710.55990.55994.935.430.763137.327.34--8.6917.949.9122.7325.2732.3511.3916.603.2567.500.027436.24-25.014.00-59.259.975.8530.26
Safe Fertility Group Pcl911.93m232.30m5.14bn--22.112.9917.665.630.76430.76433.005.660.55218.2938.88--13.98--15.19--55.84--25.31--12.7178.880.0455--16.79--24.66------
Ekachai Medical Care PCL1.27bn274.57m5.29bn568.0019.922.3014.334.170.34140.34141.612.960.512920.9912.882,230,030.0011.3919.2912.6521.9545.1542.5022.2128.885.56--0.035154.3415.2713.63-46.0820.46-9.0114.15
Nonthavej Hospital PCL2.50bn391.12m5.36bn1.64k13.702.169.442.142.442.4415.6515.540.848633.0513.591,529,459.0013.2611.5215.7212.7830.8229.6215.6214.082.81--0.0060.209.592.3829.010.046422.18-5.00
Thai Nakarin Hospital PCL2.57bn428.41m6.30bn1.17k14.712.2011.492.452.382.3814.3015.920.80242.0711.20--13.3513.2315.2314.9928.3026.6816.6514.694.47--0.002129.58-7.532.30-17.58-0.310639.200.00
Mahachai Hospital PCL6.72bn269.55m7.44bn422.0027.603.197.581.111.681.6842.0114.580.554627.097.2315,929,200.002.461.633.592.5222.2722.614.433.700.53552.150.685934.499.9022.88-25.0116.77-16.3615.88
Rajthanee Hospital PCL2.42bn428.94m7.47bn1.11k17.463.5413.053.091.431.438.047.040.636833.794.752,173,544.0011.1623.9614.5432.8231.3338.7917.5226.301.0524.360.320677.94-30.248.14-59.2210.5236.4411.38
Chiang Mai Ram Medical Business PCL5.17bn241.91m7.65bn1.59k31.561.908.561.480.05960.05961.280.99140.399133.437.463,241,176.003.043.415.715.9923.4623.637.629.050.31099.700.357487.27-2.675.18-56.78-10.322.731.13
Wattanapat Hospital Trang PCL1.71bn183.44m8.01bn538.0041.185.3325.284.680.2890.2892.752.230.672525.448.94--7.304.708.345.5328.8425.8210.857.791.315.540.397759.1227.4218.45-19.6712.541.879.86
Klinique Medical Clinic PCL2.46bn294.83m9.19bn1.05k31.155.1718.093.731.341.3411.208.080.85086.4446.002,342,106.0010.1813.5214.0523.0952.8856.5811.9712.901.48--0.23--39.4123.1040.4576.6937.97--
Data as of Jun 14 2024. Currency figures normalised to Mahachai Hospital PCL's reporting currency: Thai Baht THB
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.